Tag: Prescription Drugs
β-Blockers Not Beneficial After MI Without Reduced Left Ventricular Ejection Fraction
Second study shows beneficial effects for patients with myocardial infarction and mildly reduced LVEF
Women Have Worse Outcomes Than Men With Beta-Blockers After Acute MI
Incidence of primary end point of death, MI, heart failure hospitalization up with beta-blockers in women, but not in men
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosing
Cannabis-Based Medical Products Aid Primary Insomnia
Findings seen in as little as one month of treatment through 18 months of treatment
FDA Now Providing Daily Updates on Adverse Events
To increase transparency, the agency is publishing data from the FDA Adverse Event Reporting System daily rather than quarterly
Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis
No reduction seen in the composite outcome of cardiovascular mortality, hospitalization due to heart failure
Cancer Survivors More Likely to Take Rx for Mental Health Conditions
However, disparities exist among cancer survivors by race and health coverage
Treatment Response to Antiseizure Medications Can Take More Than One Year
Most participants with newly diagnosed focal episodes achieve seizure freedom; 27 percent become seizure-free with first ASM
Benefits of Long-Term Routine Lab Drug Toxicity Monitoring Unclear in RA
New very abnormal results mostly occur after DMARD dose increase, often already known or suspected
Discontinuation of Medical Cannabis Common in Musculoskeletal Pain
Many patients discontinue medical cannabis within one year, with higher rates for older patients
